The AI engine Fit Assessment
BetaThe company will be attending ViVE 2025 Event
Blurb
HQ Location
Founded
Employees
Total funding raised
Last Funding Event
Smart insights
Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. The company was founded in 2019 and is based in Baltimore, Maryland.